SOXL ranks 4th and CURE 7th of 30 funds in the 3x Leveraged Long Category.
CURE vs SOXL
4.7%by weight
SOXL −0.19pt a year
0.94%0.75%
SOXL 1097.7×the volume
64.4K70.7M
SOXL +17.9pt
+21.5%+39.4%
CURE vs SOXL Performance
+43.1%+66.7%
- CURE 0.94%
- SOXL 0.75%, better
- CURE $199M
- SOXL $24.3B
- CURE +84.6%, better
- SOXL +61.4%
- CURE 0.75%, better
- SOXL 0.12%
- CURE 67
- SOXL 43
- CURE 64.4K sh
- SOXL 70.7M sh, better
- CURE $165.72
- SOXL $102.45
ETF.net Grade
| Pillar | CURE | SOXL |
|---|---|---|
| Cost | A78 | A100Higher |
| Mission | ||
| Risk | A75Higher | D32 |
| Tradability | B58 | A79Higher |
| Holdings | ||
| Durability | C53 | B69Higher |
Rank among 3x Leveraged Long funds
Same Category. CURE and SOXL are both graded against the same 30 3x Leveraged Long funds, so their Grades compare head to head.
Our read on each fund
CUREA
SOXLA
In short
CURE Healthcare is the market's defensive sector. CURE straps three-times daily leverage to it, aiming for 300% of the Health Care Select Sector Index's daily move across drugmakers, insurers and device names. A trading tool with a one-day clock, running since 2011.
SOXL A 3x bet on chip stocks that resets every single day. Direxion launched it in 2010, long before AI made semiconductors the market's main event, and it is now one of the most heavily traded leveraged funds out there.
Stated mandate
CURE The fund seeks daily investment results, before fees and expenses, equal to 300% of the performance of the Health Care Select Sector Index.
SOXL It is designed to deliver a daily result three times the performance of the NYSE Semiconductor Index, before fees and expenses, with the objective applying for a single day.
Why people hold it
Worth knowing
CURE vs SOXL Holdings
How CURE and SOXL differ
4.7%
Shared holdings make up 8.2% of CURE and 4.7% of SOXL.
Level by level
- Holdings4.7%
- Country89.3%
Sector
No Sector split for CURE.
Country, concentration and asset class
Country
| Country | More in CUREMore in SOXL | CURE | SOXL |
|---|---|---|---|
| United States | CURE +10.7 points | 100.0% | 89.3% |
| Taiwan | SOXL +4.7 points | 0.0% | 4.7% |
| South Korea | SOXL +3.0 points | 0.0% | 3.0% |
| Netherlands | SOXL +1.5 points | 0.0% | 1.5% |
| Israel | SOXL +1.1 points | 0.0% | 1.1% |
| Singapore | SOXL +0.4 points | 0.0% | 0.4% |
Concentration
- CURE86.4%
- SOXL74.3%
- CURE62
- SOXL32
Asset class
- CURE
- Equity
- SOXL
- Equity
Holdings
- Only in CURE61
- In both1
- Only in SOXL31
Only in CURE
61 securities, 23.0% of CURE by weight
- Eli Lilly & Co3.40%
- Goldman Sachs Fin Gov 465 Institut2.34%
- Johnson & Johnson2.05%
- AbbVie Inc1.59%
- UnitedHealth Group Inc1.14%
- Merck & Co. Inc.1.12%
- Thermo Fisher Scientific Inc0.81%
- Amgen Inc0.77%
- Gilead Sciences Inc0.64%
- Abbott Laboratories0.56%
- Pfizer Inc0.53%
- Intuitive Surgical Inc0.49%
- Danaher Corp0.46%
- Vertex Pharmaceuticals Inc0.42%
- Bristol-Myers Squibb Co0.39%
- Medtronic PLC0.37%
- Cvs Health Corp0.36%
- Mckesson Corp0.35%
- Stryker Corp0.34%
- Elevance Health Inc0.28%
- Moderna Inc0.26%
- Regeneron Pharmaceuticals0.25%
- The Cigna Group0.24%
- Hca Healthcare Inc0.22%
- Cencora Inc0.20%
- Boston Scientific Corp0.19%
- Cardinal Health Inc0.18%
- Edwards Lifesciences Corp0.17%
- Becton Dickinson and Co0.17%
- Agilent Technologies Inc0.16%
- Humana Inc0.16%
- Waters Corp0.15%
- Veeva Systems Inc-Class A0.14%
- Idexx Laboratories Inc0.14%
- Iqvia Holdings Inc0.14%
- Illumina Inc0.14%
- Biogen Inc0.11%
- Resmed Inc0.11%
- Ge Healthcare Technology0.11%
- Mettler-Toledo International0.11%
- Centene Corp0.10%
- Zoetis Inc0.10%
- Dexcom Inc0.09%
- Labcorp Holdings Inc0.09%
- West Pharmaceutical Services0.09%
- Quest Diagnostics Inc0.09%
- Steris PLC0.07%
- Viatris Inc0.07%
- Incyte Corp0.06%
- Zimmer Biomet Holdings Inc0.06%
Only in SOXL
31 securities, 23.4% of SOXL by weight
- Jp Morgan 100 Us Trsy Capital 31632.46%
- Advanced Micro Devices1.99%
- Intel Corp1.70%
- Micron Technology Inc1.61%
- NVIDIA Corp1.60%
- Broadcom Inc1.54%
- Texas Instruments Inc0.99%
- Analog Devices Inc0.99%
- Qualcomm Inc0.90%
- Marvell Technology Inc0.85%
- Kla Corp0.79%
- Nxp Semiconductors NV0.77%
- Applied Materials Inc0.76%
- Lam Research Corp0.70%
- Taiwan Semiconductor-Sp Adr0.66%
- Monolithic Power Systems Inc0.65%
- Sk Hynix Inc-Adr0.62%
- Teradyne Inc0.53%
- Microchip Technology Inc0.49%
- Astera Labs Inc0.47%
- On Semiconductor0.33%
- Credo Technology Group Holdi0.32%
- Asml Holding Nv-Ny Reg Shs0.31%
- Entegris Inc0.28%
- Tower Semiconductor Ltd0.23%
- Ase Technology Holding -Adr0.21%
- Macom Technology Solutions H0.21%
- Cerebras Systems Inc - A0.13%
- United Microelectron-Sp Adr0.12%
- Arm Holdings Plc-Adr0.09%
- Stmicroelectronics Nv-Ny Shs0.09%
Weight gaps
All 1 Holdings in both funds, largest gap first.
| Holding | More in CUREMore in SOXL | CURE | SOXL |
|---|---|---|---|
| Goldman Finl Sq Trsry Inst 506 | CURE +0.60 points | 2.54% | 1.94% |
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
CURE vs SOXL Cost
Overpaying CURE vs SOXL
$3,222
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
CURE 0.94%
$17,704
SOXL 0.75%
$14,482
Cost over time
Year by year
| Year | CURE | SOXL | Overpaying |
|---|---|---|---|
| 10 | $1,661 | $1,336 | $325 |
| 20 | $6,260 | $5,078 | $1,182 |
| 30 | $17,704 | $14,482 | $3,222 |
- 0.94%CURE
- 0.75%SOXL, cheaper
- Middle half of 3x Leveraged Long funds
- Median 0.96%
SOXL cheapest of 30 funds
CURE 7th cheapest of 30 funds
CURE vs SOXL Dividends
- CURE 0.75%, better
- SOXL 0.12%
- CURE $1.26
- SOXL $0.09
- CURE $0.32
- SOXL $0.09
- CURE Sep 22, 2026
- SOXL Sep 22, 2026
- CURE Sep 29, 2026
- SOXL Sep 29, 2026
- CURE Quarterly
- SOXL Annual
Distribution history
CURE vs SOXL Risk
Fall from peak · 5 years
- CURE
- SOXL
Risk facts
- Volatility
- CURE 44.6%, betterSOXL 137.2%
- Return per unit of risk
- CURE 0.71SOXL 0.90, better
- Worst fall
- CURE −52.3%, betterSOXL −90.5%
- Market sensitivity
- CURE 1.27SOXL 7.64
Popular comparisons
- 0.94% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.75% · 0.78%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.94%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.75% · 0.94%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.94% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.75% · 0.88%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.